Results 381 to 390 of about 10,805,577 (430)
Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases. [PDF]
Suzuki N+19 more
europepmc +1 more source
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review. [PDF]
Gajewska A+5 more
europepmc +1 more source
Dietary index for gut microbiota, a novel protective factor for the prevalence of chronic kidney diseases in the adults: insight from NHANES 2007-2018. [PDF]
Xiao Y+6 more
europepmc +1 more source
Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases. [PDF]
Ho QY, Hester J, Issa F.
europepmc +1 more source
Methyltransferase-like 3 represents a prospective target for the diagnosis and treatment of kidney diseases. [PDF]
Song B, Wu X, Zeng Y.
europepmc +1 more source
Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors. [PDF]
Hejazian SM+7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acute Kidney Disease to Chronic Kidney Disease
Critical Care Clinics, 2021Acute kidney injury (AKI) and chronic kidney disease are common interconnected syndromes that represent a public health problem. Acute kidney disease (AKD) is defined as the post-AKI status of acute or subacute kidney damage/dysfunction manifested by persistence of AKI beyond 7 to 90 days after the initial AKI diagnosis.
Javier A. Neyra, Lakhmir S. Chawla
openaire +3 more sources
Clinical Genetics, 2014
Fabry disease (FD) is an X‐linked disease in which mutations of the GLA gene result in a deficiency of the enzyme α‐galactosidase A and subsequent progressive, intralysosomal deposition of undegraded glycosphingolipid products, primarily globotriaosylceramide, in multiple organs.
PISANI, ANTONIO+6 more
openaire +5 more sources
Fabry disease (FD) is an X‐linked disease in which mutations of the GLA gene result in a deficiency of the enzyme α‐galactosidase A and subsequent progressive, intralysosomal deposition of undegraded glycosphingolipid products, primarily globotriaosylceramide, in multiple organs.
PISANI, ANTONIO+6 more
openaire +5 more sources